Central Line Associated Blood-Stream Infection (CLA-BSI) rate: Difference between revisions
Jump to navigation
Jump to search
Ttenbergen (talk | contribs) (Created page with "{{Reporting Indicators | description = CLA-BSI defined using CDC case definit...") |
|||
Line 15: | Line 15: | ||
==Sampling Plan / Procedure== | ==Sampling Plan / Procedure== | ||
All patients with one or more CVCs are included in the sample. | |||
===Includion Criteria=== | ===Includion Criteria=== | ||
{{discuss | who=Julie | question= What are the details? }} | {{discuss | who=Julie | question= What are the details? }} |
Revision as of 13:28, 2019 August 12
CLA-BSI defined using CDC case definition.
Indicators | |
Indicator: | Central Line Associated Blood-Stream Infection (CLA-BSI) rate |
Created/Raw: | Created |
Program: | Critical Care |
Start Date: | |
End Date: | |
Reports: | Directors Quarterly and Annual Report (Critical Care), STB ICUs VAP Rate, CLIBSI Rate Summary, WRHA ICU Hospital-Acquired Conditions |
QI domain
- Safe
Significance
CLA-BSIs increase morbidity, mortality and costs. It can be prevented using evidence-based interventions. This measure can be used to detect changes related to implementation or lack of adherence to these best practices.
Sampling Plan / Procedure
All patients with one or more CVCs are included in the sample.
Includion Criteria
Exclusion Criteria
Frequency
Definition and Derivation
CLA-BSI per 1000 Central line days.
Numerator
Denominator
Data Sources
SAS Program
Report Users
Related articles
Related articles: |